Response to "Use of Qualitative Data to Support Content Validity of Performance-Based Cognitive Outcome Assessments"
Ther Innov Regul Sci
.
2018 Jul;52(4):405-406.
doi: 10.1177/2168479018771309.
Authors
Michael T Ropacki
1
,
Kristin Hannesdottir
2
,
Suzanne Hendrix
3
,
Mark Forrest Gordon
4
,
Diane Stephenson
5
,
Stephen Joel Coons
6
,
Robert A Stern
7
;
Critical Path Institute’s Coalition Against Major Diseases and Patient-Reported Outcome Consortium Cognition Working Group
Affiliations
1
Strategic Global Research & Development, Half Moon Bay, CA, USA.
2
Novartis Institutes for Biomedical Research Inc, Cambridge, MA, USA.
3
Pentara Corporation, Salt Lake City, UT, USA.
4
TEVA Pharmaceuticals USA Inc, North Wales, PA, USA.
5
Coalition Against Major Diseases, Critical Path Institute, Tucson, AZ, USA.
6
Patient-Reported Outcome Consortium, Critical Path Institute, Tucson, AZ, USA.
7
Alzheimer's Disease Center, Boston University School of Medicine, Boston, MA, USA.
PMID:
29996731
DOI:
10.1177/2168479018771309
No abstract available
Publication types
Letter